What is ABECMA? ABECMA (idecabtagene vicleucel) is a prescription medicine for the treatment of multiple myeloma in patients who have received at least four kinds of treatment regimens that have not worked or have stopped working. ABECMA is a medicine made from your own white blood cells; the cells are genetically modified to recognize and attack your multiple myeloma cells.

This website is best viewed using the horizontal display on your tablet device.

This website is best viewed using the vertical display on your mobile device.

Real patient stories
—changed by

As the first CAR T cell therapy for MM,
ABECMA is unlike other treatments you’ve
received before. Hear more about ABECMA
and the treatment process from real MM
patients and a caregiver.

Mary's ABECMA® (idecabtagene vicleucel) patient story video

Mary’s Story

I cannot even begin to
describe how grateful I am
for every day I’ve been given.
I want to share my story."


Dana's ABECMA® (idecabtagene vicleucel) patient story video

Dana’s Story

I want to thank Susan for all
the ways she’s helped me,
from the beginning of the
journey when I was first
diagnosed until now. She’s
been right by my side and
has helped me every step of
the way.”


Dana is a former patient who received ABECMA.

Each person was compensated by Bristol Myers Squibb for sharing their story. Your experience and results may vary.

Share your ABECMA story

If you are interested in sharing your MM
diagnosis and ABECMA treatment
journey with others, please visit www.SharetoInspire.com or call us at 1-855-436-58661-855-436-5866.

CAR=chimeric antigen receptor; MM=multiple myeloma.